A study examining 1031 hospitalized COVID-19 patients found that aging significantly impacts immune responses, viral dynamics, and the nasal microbiome, with older adults experiencing more severe disease symptoms and delayed viral clearance.
Pfizer’s first-ever bispecific antibody Elrexfio holds promise in multiple myeloma
Elrexfio’s higher dosage and limited trials may hinder its ability to rival Tecvayli. Credit: Kateryna Kon via Shutterstock. The US Food and Drug Administration’s recent